Sutro Biopharma, Inc. SEC filings STRO

Sutro Biopharma, Inc. has 624 filings in SEC EDGAR's recent list, going back to Nov 8, 2006. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Sutro Biopharma, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Sep 22, 2026 Sep 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 12, 2026 Aug 12, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 30, 2026 —
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
8-K Current report
Shareholder vote results
Jun 8, 2026 Jun 5, 2026
4 Insider transaction Jun 2, 2026 Jun 2, 2026
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 1, 2026 —
ARS Annual report to shareholders Apr 22, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 22, 2026 —
DEF 14A Proxy statement Apr 22, 2026 Jun 5, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 21, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 21, 2026 —
EFFECT Filing Apr 1, 2026 —
424B3 Prospectus Apr 1, 2026 —
CORRESP Letter to the SEC Mar 30, 2026 —
UPLOAD Letter from the SEC Mar 27, 2026 —
S-3 Shelf registration Mar 23, 2026 —
S-8 Employee stock plan registration Mar 23, 2026 —
10-K Annual report Mar 23, 2026 Dec 31, 2025
8-K Current report
Agreement ended, Results of operations
Mar 23, 2026 Mar 23, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 2, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 18, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Feb 10, 2026 Feb 9, 2026
424B5 Prospectus supplement Feb 10, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 29, 2026 —
144 Notice of proposed sale Jan 20, 2026 —
4 Insider transaction Dec 29, 2025 Dec 23, 2025
4 Insider transaction Dec 29, 2025 Dec 23, 2025
4 Insider transaction Dec 29, 2025 Dec 23, 2025
4 Insider transaction Dec 29, 2025 Dec 23, 2025
4 Insider transaction Dec 29, 2025 Dec 23, 2025
4 Insider transaction Dec 29, 2025 Dec 23, 2025
4 Insider transaction Dec 29, 2025 Dec 23, 2025
4 Insider transaction Dec 29, 2025 Dec 23, 2025
4 Insider transaction Dec 29, 2025 Dec 23, 2025
4 Insider transaction Dec 29, 2025 Dec 23, 2025
4 Insider transaction Dec 29, 2025 Dec 23, 2025
8-K Current report
Other events
Dec 17, 2025 Dec 17, 2025
4 Insider transaction Dec 16, 2025 Dec 12, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Dec 3, 2025 Dec 1, 2025
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 23, 2025 —
4 Insider transaction Oct 16, 2025 Oct 15, 2025
4 Insider transaction Oct 16, 2025 Oct 15, 2025
4 Insider transaction Oct 16, 2025 Oct 15, 2025
4 Insider transaction Oct 16, 2025 Oct 15, 2025
4 Insider transaction Oct 16, 2025 Oct 15, 2025
8-K Current report
Exit or restructuring costs
Sep 29, 2025 Sep 29, 2025
4 Insider transaction Sep 22, 2025 Sep 18, 2025
3/A Filing Sep 12, 2025 Apr 4, 2025
4 Insider transaction Aug 26, 2025 Jul 8, 2025
4 Insider transaction Aug 26, 2025 Aug 9, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 16, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jun 30, 2025 —
8-K Current report
Listing notice
Jun 25, 2025 Jun 20, 2025
8-K Current report
Shareholder vote results
Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 2, 2025 Jun 2, 2025
3 Initial insider ownership Jun 2, 2025 Jun 2, 2025
8-K Current report
Officer or director change
Jun 2, 2025 Jun 2, 2025
S-8 Employee stock plan registration May 30, 2025 —
4 Insider transaction May 19, 2025 May 15, 2025
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Jun 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 17, 2025 —
4 Insider transaction Apr 15, 2025 Apr 11, 2025
PRE 14A Preliminary proxy statement Apr 14, 2025 Jun 6, 2025
8-K Current report
Officer or director change
Apr 14, 2025 Apr 10, 2025
4 Insider transaction Apr 8, 2025 Apr 4, 2025
4 Insider transaction Apr 8, 2025 Apr 4, 2025
4 Insider transaction Apr 8, 2025 Apr 4, 2025
4 Insider transaction Apr 8, 2025 Apr 4, 2025
4 Insider transaction Apr 8, 2025 Apr 4, 2025
3 Initial insider ownership Apr 8, 2025 Apr 4, 2025
SCHEDULE 13G Ownership over 5% (passive) Apr 4, 2025 —
10-K Annual report Mar 13, 2025 Dec 31, 2024
8-K Current report
Results of operations, Exit or restructuring costs, Officer or director change
Mar 13, 2025 Mar 13, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
S-8 Employee stock plan registration Feb 27, 2025 —
8-K Current report
Other events
Dec 10, 2024 Dec 10, 2024
4 Insider transaction Dec 3, 2024 Dec 1, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 13, 2024 —
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 4, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 4, 2024 —
4 Insider transaction Sep 20, 2024 Sep 18, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 13, 2024 Aug 13, 2024
4 Insider transaction Aug 13, 2024 Aug 9, 2024
4 Insider transaction Aug 12, 2024 Aug 8, 2024
3 Initial insider ownership Aug 12, 2024 Aug 8, 2024
8-K Current report
Officer or director change
Aug 12, 2024 Aug 8, 2024
4 Insider transaction Jul 10, 2024 Jul 8, 2024
3 Initial insider ownership Jul 10, 2024 Jul 8, 2024
4 Insider transaction Jun 10, 2024 Jun 6, 2024
8-K Current report
Shareholder vote results
Jun 10, 2024 Jun 6, 2024
4 Insider transaction Jun 10, 2024 Jun 6, 2024
4 Insider transaction Jun 10, 2024 Jun 6, 2024
4 Insider transaction Jun 10, 2024 Jun 6, 2024
4 Insider transaction Jun 10, 2024 Jun 6, 2024
4 Insider transaction Jun 10, 2024 Jun 6, 2024
4 Insider transaction Jun 10, 2024 Jun 6, 2024
4 Insider transaction Jun 10, 2024 Jun 6, 2024
DEFA14A Additional proxy material May 17, 2024 —
10-Q Quarterly report May 13, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 13, 2024 May 13, 2024
4 Insider transaction May 3, 2024 May 1, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 26, 2024 Jun 6, 2024
DEFA14A Additional proxy material Apr 26, 2024 —
4 Insider transaction Apr 12, 2024 Apr 11, 2024
SC 13G Ownership over 5% (passive) Apr 5, 2024 —
8-K Current report
Material agreement
Apr 2, 2024 Apr 2, 2024
424B5 Prospectus supplement Apr 2, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Apr 2, 2024 Mar 29, 2024
10-K Annual report Mar 25, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 25, 2024 Mar 25, 2024
4/A Filing Mar 22, 2024 Mar 5, 2024
4/A Filing Mar 22, 2024 Mar 5, 2024
4/A Filing Mar 22, 2024 Mar 5, 2024
4 Insider transaction Mar 7, 2024 Mar 5, 2024
4 Insider transaction Mar 7, 2024 Mar 5, 2024
4 Insider transaction Mar 7, 2024 Mar 5, 2024
4 Insider transaction Mar 7, 2024 Mar 5, 2024
4 Insider transaction Mar 7, 2024 Mar 5, 2024
4 Insider transaction Mar 7, 2024 Mar 5, 2024
4 Insider transaction Mar 7, 2024 Mar 5, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 4, 2024 Feb 29, 2024
S-8 Employee stock plan registration Feb 27, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
STRO (Nasdaq)
Fiscal year ends
December 31
Headquarters
South San Francisco, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1382101
Former names
SUTRO BIOPHARMA INC (until Nov 8, 2018); Fundamental Applied Biology Inc (until Oct 24, 2007)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.